Recalls / Active ingredient / Belimumab
Belimumab
1 FDA drug recall involving the active ingredient “Belimumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-04-21 | Class II | BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK. | Mckesson Medical-Surgical Inc. Corporate Office |